Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Root

Showing results (91-100 of 200) with videos related to

Pageof 20
Sort By:
Nature Genetics|August 22, 2018
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitryAdam D Durbin, Mark W Zimmerman, Neekesh V Dharia, et al.
The Journal of Experimental Medicine|March 12, 2014
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaMarcus Järås, Peter G Miller, Lisa P Chu, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Chromatin Perturbation Promotes Susceptibility to Hypomethylating AgentsConstanze Schneider, Gabriela Alexe, Lucy A Merickel, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014
In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogeneGavin P Dunn, Hiu Wing Cheung, Pankaj K Agarwalla, et al.
Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the <i>VHL</i> tumor suppressor and the <i>EZH1</i> histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.
Nature|November 23, 2018
DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cellsYizhou Joseph He, Khyati Meghani, Marie-Christine Caron, et al.
Elife|June 1, 2017
Synergistic interactions with PI3K inhibition that induce apoptosisYaara Zwang, Oliver Jonas, Casandra Chen, et al.
Cell|August 21, 2012
Cancer vulnerabilities unveiled by genomic lossDeepak Nijhawan, Travis I Zack, Yin Ren, et al.
Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Pageof 20

Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Nature Genetics|August 22, 2018
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitryAdam D Durbin, Mark W Zimmerman, Neekesh V Dharia, et al.
The Journal of Experimental Medicine|March 12, 2014
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaMarcus Järås, Peter G Miller, Lisa P Chu, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Chromatin Perturbation Promotes Susceptibility to Hypomethylating AgentsConstanze Schneider, Gabriela Alexe, Lucy A Merickel, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014
In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogeneGavin P Dunn, Hiu Wing Cheung, Pankaj K Agarwalla, et al.
Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the <i>VHL</i> tumor suppressor and the <i>EZH1</i> histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.
Nature|November 23, 2018
DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cellsYizhou Joseph He, Khyati Meghani, Marie-Christine Caron, et al.
Elife|June 1, 2017
Synergistic interactions with PI3K inhibition that induce apoptosisYaara Zwang, Oliver Jonas, Casandra Chen, et al.
Cell|August 21, 2012
Cancer vulnerabilities unveiled by genomic lossDeepak Nijhawan, Travis I Zack, Yin Ren, et al.
Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Pageof 20